Bob Harrington Receives American Heart Association Prestigious Award

The American Heart Association (AHA) gives a small number of highly-regarded awards during its annual meeting, which took place November 11-14 in Anaheim, California. The recipient of its Clinical Research Prize for 2017, given for outstanding achievement in clinical cardiovascular science, was Bob Harrington, MD, chairman of the Stanford Department of Medicine.

Harrington is internationally-recognized for designing and leading innovative clinical trials that aim to improve the care of patients with coronary heart disease. He has spent many years focusing on reducing blood clotting complications by working with researchers and pharmaceutical companies worldwide to test new therapies in large trials.

In his description of the awardee, AHA President John Warner, MD, of the University of Texas Southwestern, said Harrington “has focused his investigative efforts on improving the care of coronary heart disease patients with blood-clotting complications, through a series of landmark studies that have become pivotal to gaining regulatory approval of anti-thrombotic medications across multiple indications.”

The Clinical Research Prize is an annual award to a single individual for “outstanding achievement in clinical cardiovascular science.”